Willis Investment Counsel’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Sell
64,490
-506
-0.8% -$137K 0.94% 49
2025
Q4
$16.3M Buy
64,996
+3,818
+6% +$1.01M 0.84% 54
2025
Q3
$17.6M Sell
61,178
-4,728
-7% -$1.27M 0.96% 48
2025
Q2
$17.3M Buy
65,906
+40
+0.1% +$9.74K 1.01% 47
2025
Q1
$15.3M Buy
65,866
+29
+0% +$7.04K 1.03% 42
2024
Q4
$15.1M Buy
65,837
+834
+1% +$191K 0.99% 46
2024
Q3
$14.5M Buy
65,003
+971
+2% +$213K 0.94% 46
2024
Q2
$13M Buy
64,032
+41
+0.1% +$8.34K 0.9% 50
2024
Q1
$14M Buy
63,991
+149
+0.2% +$32.8K 0.96% 44
2023
Q4
$14.5M Buy
63,842
+52
+0.1% +$10.9K 1.02% 38
2023
Q3
$12.8M Sell
63,790
-34,881
-35% -$7.36M 0.97% 40
2023
Q2
$20.5M Buy
98,671
+1,423
+1% +$276K 1.33% 29
2023
Q1
$19.2M Buy
97,248
+1,494
+2% +$307K 1.25% 31
2022
Q4
$19.4M Sell
95,754
-538
-0.6% -$105K 1.24% 33
2022
Q3
$16.9M Sell
96,292
-122
-0.1% -$25K 1.23% 33
2022
Q2
$19.4M Buy
96,414
+1,521
+2% +$324K 1.19% 35
2022
Q1
$21.5M Buy
94,893
+3,578
+4% +$841K 1.14% 37
2021
Q4
$24.6M Sell
91,315
-3,878
-4% -$960K 1.3% 32
2021
Q3
$23M Buy
95,193
+5,563
+6% +$1.4M 1.32% 29
2021
Q2
$21.2M Buy
89,630
+15,169
+20% +$3.46M 1.26% 33
2021
Q1
$16.3M Sell
74,461
-125
-0.2% -$25.1K 0.99% 37
2020
Q4
$13M Buy
74,586
+32
+0% +$5.53K 0.89% 41
2020
Q3
$12.1M Sell
74,554
-20
-0% -$3.17K 1.08% 37
2020
Q2
$10.6M Buy
74,574
+2,543
+4% +$352K 0.83% 48
2020
Q1
$7.82M Buy
72,031
+12,722
+21% +$1.83M 0.65% 54
2019
Q4
$8.62M Buy
59,309
+291
+0.5% +$42K 0.56% 59
2019
Q3
$8.52M Buy
59,018
+882
+2% +$129K 0.57% 60
2019
Q2
$8.63M Sell
58,136
-879
-1% -$123K 0.58% 62
2019
Q1
$15.2M Buy
59,015
+3,172
+6% +$391K 1.05% 46
2018
Q4
$6.06M Buy
55,843
+565
+1% +$75.7K 0.45% 79
2018
Q3
$8.25M Buy
55,278
+46
+0.1% +$7K 0.57% 71
2018
Q2
$8.52M Buy
55,232
+280
+0.5% +$42.3K 0.63% 69
2018
Q1
$7.64M Buy
54,952
+18,199
+50% +$2.67M 0.59% 73
2017
Q4
$5.04M Sell
36,753
-24
-0.1% -$3.17K 0.35% 90
2017
Q3
$4.77M Sell
36,777
-104
-0.3% -$13.9K 0.34% 89
2017
Q2
$4.88M Buy
36,881
+395
+1% +$48.4K 0.37% 90
2017
Q1
$4.5M Buy
36,486
+914
+3% +$108K 0.34% 96
2016
Q4
$3.92M Buy
35,572
+408
+1% +$45.3K 0.29% 97
2016
Q3
$4.15M Buy
35,164
+186
+0.5% +$21.9K 0.33% 95
2016
Q2
$3.92M Buy
34,978
+58
+0.2% +$6.24K 0.33% 92
2016
Q1
$3.51M Buy
+34,920
New +$3.35M 0.31% 96
2014
Q4
Sell
-86,765
Closed -$7.58M 128
2014
Q3
$7.58M Buy
86,765
+2,090
+2% +$189K 0.8% 56
2014
Q2
$7.45M Buy
84,675
+3,335
+4% +$289K 0.73% 61
2014
Q1
$6.86M Buy
81,340
+1,775
+2% +$142K 0.7% 66
2013
Q4
$6.25K Buy
79,565
+21,656
+37% +$1.85M 0.29% 64
2013
Q3
$4.98M Hold
57,909
0.57% 73
2013
Q2
$4.98M Buy
+57,909
New +$4.81M 0.57% 73

Other funds holding LH

Willis Investment Counsel's LH Position: Q1 2026 in Review

Willis Investment Counsel reduced its Labcorp (LH) stake by 0.78% in Q1 2026, selling an estimated $137K and leaving 64,490 shares worth $17.2M. The position accounts for 0.94% of the portfolio, ranked #49.

Willis Investment Counsel first reported a position in LH in Q2 2013 and has held it in 47 quarters since. The position peaked at $24.6M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Willis Investment Counsel held 64,490 shares of Labcorp worth $17.2M as of Q1 2026.
  • Willis Investment Counsel sold 506 Labcorp shares in Q1 2026, an estimated $137K.
  • Labcorp made up 0.94% of Willis Investment Counsel's portfolio in Q1 2026, its #49 holding.
  • Willis Investment Counsel first reported a position in Labcorp in Q2 2013 and has held it in 47 quarters since.
  • Willis Investment Counsel's Labcorp position peaked at $24.6M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.